No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CTKB Cytek Biosciences
- 5.610
- -0.070-1.23%
Close Jun 18 16:00 ET
- 5.500
- -0.110-1.96%
Post 19:30 ET
736.44MMarket Cap-62333P/E (TTM)
5.730High5.610Low290.35KVolume5.650Open5.680Pre Close1.64MTurnover0.27%Turnover RatioLossP/E (Static)131.27MShares9.87052wk High1.88P/B595.80MFloat Cap3.80052wk Low--Dividend TTM106.20MShs Float28.700Historical High--Div YieldTTM2.11%Amplitude3.800Historical Low5.634Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Cytek Biosciences Announces $50 Million Stock Repurchase Program
Cytek Biosciences to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference
FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday
Health care stocks were leaning lower premarket Wednesday as the Health Care Select Sector SPDR Fund (XLV) retreated 0.6% and the iShares Biotechnology ETF (IBB) declined 0.2% recently. SurModics (SRD
Express News | Cytek Biosciences Says Its 1-laser And 2-laser 6-color TBNK Reagent Cocktails Have Received China NMPA Approval For Clinical Diagnostic Use
Express News | 1-Laser and 2-Laser 6-Color Tbnk Reagents From Cytek® Biosciences Approved for Clinical Use in China
Cytek Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Today Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, officially announced its Enhanced Small Particle (ESP™) Detection Option for its flagship Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
Comments
$Cytek Biosciences(CTKB.US$
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
On May 28, 2024, Cytek Biosciences (Nasdaq: CTKB) announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails received approval from China's National Medical Products Administration (NMPA) for clinical use. These reagents, used in the Cytek Northern Lights-Clinical (NL-CLC) cell analysis systems, aid in diagnosing and monitoring immune-related conditions...
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
On May 28, 2024, Cytek Biosciences (Nasdaq: CTKB) announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails received approval from China's National Medical Products Administration (NMPA) for clinical use. These reagents, used in the Cytek Northern Lights-Clinical (NL-CLC) cell analysis systems, aid in diagnosing and monitoring immune-related conditions...
2
$Cytek Biosciences(CTKB.US$
NEWS
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Cytek Biosciences has introduced the Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ systems. This upgrade allows researchers to detect subcellular particles, such as extracellular vesicles (EVs), with superior sensitivity and resolution. The global EV market is projected to grow significantly, from $227.5...
NEWS
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Cytek Biosciences has introduced the Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ systems. This upgrade allows researchers to detect subcellular particles, such as extracellular vesicles (EVs), with superior sensitivity and resolution. The global EV market is projected to grow significantly, from $227.5...
Gapping up
In reaction to earnings/guidance:
• $PDD Holdings(PDD.US$ +15% (The company said its performance was boosted by a recovery in consumer sentiment.)
Other news:
• $Hill International(HIL.US$ +20% (Hill International and GISI announce enhancements to their strategic merger agreement)
• $FiscalNote Holdings(NOTE.US$ +11.3% (files for 87,504,863 share common stock offering, relates to warrants)
• $Cytek Biosciences(CTKB.US$ +2.9% (fi...
In reaction to earnings/guidance:
• $PDD Holdings(PDD.US$ +15% (The company said its performance was boosted by a recovery in consumer sentiment.)
Other news:
• $Hill International(HIL.US$ +20% (Hill International and GISI announce enhancements to their strategic merger agreement)
• $FiscalNote Holdings(NOTE.US$ +11.3% (files for 87,504,863 share common stock offering, relates to warrants)
• $Cytek Biosciences(CTKB.US$ +2.9% (fi...
14
1
$Cytek Biosciences(CTKB.US$ what's the word?
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg